“cormorant-asset-management” Archives

in
Entry Author Date Location
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor 08/17/20 Boston
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
Turning Point Prices IPO, Raising $166M to Test Cancer Drugs 04/17/19 San Diego
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs 03/22/19 San Diego
Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work 03/06/19 San Diego
Neurogene Emerges with $68M to Advance Gene Therapies to the Clinic 02/12/19 New York
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push 10/19/18 San Diego
Renovia Raises $42M to Back Digital Treatment for Incontinence 08/21/18 Boston
Entasis Therapeutics and Principia Biopharma Join the IPO Queue 08/20/18 Boston
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D 06/27/18 San Diego
Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline 02/01/18 Boston
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases 11/16/17 Boston
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
Boston Tech Watch: DraftKings, Nantero, WordStream, Tinyhood & More 03/20/17 Boston
Iconic Therapeutics Lands $10,000,000 Series C Financing 08/10/16 San Francisco
Mersana Therapeutics Receives $33,000,000 Series C Financing 06/16/16 Boston
G1 Therapeutics Hauls in $47M for Lung, Breast Cancer Trials 05/12/16 Raleigh Durham
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Quanterix Receives $46,000,000 Series D Funding 03/23/16 Boston
Page 1 of 2 next page »